BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Islim AI, Mohan M, Moon RDC, Srikandarajah N, Mills SJ, Brodbelt AR, Jenkinson MD. Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes. J Neurooncol 2019;142:211-21. [PMID: 30656531 DOI: 10.1007/s11060-019-03104-3] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Chotai S, Tang AR, Gupta R, Guidry BS, Mcdermott JR, Grisham CJ, Morone PJ, Thompson RC, Chambless LB. Matched case–control analysis of outcomes following surgical resection of incidental meningioma. J Neurooncol 2022. [DOI: 10.1007/s11060-022-04167-5] [Reference Citation Analysis]
2 Chang C, Huang C, Chou H, Tu H, Lee M, Huang C. A Pathophysiological Approach to Reduce Peritumoral Edema with Gamma Knife Radiosurgery for Large Incidental Meningiomas. Life 2022;12:1683. [DOI: 10.3390/life12111683] [Reference Citation Analysis]
3 Yamada S, Hirayama R, Iwata T, Kuroda H, Nakagawa T, Takenaka T, Kijima N, Okita Y, Kagawa N, Kishima H. Growth risk classification and typical growth speed of convexity, parasagittal, and falx meningiomas: a retrospective cohort study. J Neurosurg 2022;:1-7. [PMID: 36115061 DOI: 10.3171/2022.8.JNS221290] [Reference Citation Analysis]
4 Boaro A, Kaczmarzyk JR, Kavouridis VK, Harary M, Mammi M, Dawood H, Shea A, Cho EY, Juvekar P, Noh T, Rana A, Ghosh S, Arnaout O. Deep neural networks allow expert-level brain meningioma segmentation and present potential for improvement of clinical practice. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-19356-5] [Reference Citation Analysis]
5 Abdelrahman A, Negroni C, Sahm F, Adams CL, Urbanic-Purkart T, Khalil M, Vergura R, Morelli C, Hanemann CO. miR-497 and 219 in blood aid meningioma classification. J Neurooncol 2022. [PMID: 36076132 DOI: 10.1007/s11060-022-04126-0] [Reference Citation Analysis]
6 Byun HK, Chang WI, Lee JH, Park C, Kim IA, Kim C, Cho J, Kim EH, Chang JH, Kang S, Moon JH, Lee SH, Lee JJB, Kim IH, Suh C, Wee CW, Yoon HI. Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study. Front Oncol 2022;12:877244. [DOI: 10.3389/fonc.2022.877244] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Abdolkarimzadeh F, Ashory MR, Ghasemi-Ghalebahman A, Karimi A. A position- and time-dependent pressure profile to model viscoelastic mechanical behavior of the brain tissue due to tumor growth. Comput Methods Biomech Biomed Engin 2022;:1-13. [PMID: 35638726 DOI: 10.1080/10255842.2022.2082245] [Reference Citation Analysis]
8 Millward CP, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Crofton A, Dirven L, Georgious T, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD; EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. BMJ Open 2022;12:e057384. [PMID: 35534067 DOI: 10.1136/bmjopen-2021-057384] [Reference Citation Analysis]
9 Pikis S, Mantziaris G, Bunevicius A, Islim AI, Peker S, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, El-Shehaby AMN, Abdelkarim K, Emad RM, Delabar V, Mathieu D, Lee CC, Yang HC, Liscak R, May J, Alvarez RM, Patel DN, Kondziolka D, Bernstein K, Moreno NM, Tripathi M, Speckter H, Albert C, Bowden GN, Benveniste RJ, Lunsford LD, Jenkinson MD, Sheehan J. Stereotactic Radiosurgery Compared With Active Surveillance for Asymptomatic, Parafalcine, and Parasagittal Meningiomas: A Matched Cohort Analysis From the IMPASSE Study. Neurosurgery 2022. [PMID: 35319529 DOI: 10.1227/neu.0000000000001924] [Reference Citation Analysis]
10 Patel B, Desai R, Pugazenthi S, Butt OH, Huang J, Kim AH. Identification and Management of Aggressive Meningiomas. Front Oncol 2022;12:851758. [DOI: 10.3389/fonc.2022.851758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chang WI, Kim IH, Choi SH, Kim TM, Lee ST, Won JK, Park SH, Kim MS, Kim JW, Kim YH, Park CK, Lee JH. Risk Stratification to Define the Role of Radiotherapy for Benign and Atypical Meningioma: A Recursive Partitioning Analysis. Neurosurgery 2022. [PMID: 35262528 DOI: 10.1227/NEU.0000000000001904] [Reference Citation Analysis]
12 Islim AI, Mantziaris G, Pikis S, Chen C, Bunevicius A, Peker S, Samanci Y, Nabeel AM, Reda WA, Tawadros SR, El-shehaby AMN, Abdelkarim K, Emad RM, Delabar V, Mathieu D, Lee C, Yang H, Liscak R, May J, Alvarez RM, Moreno NM, Tripathi M, Kondziolka D, Speckter H, Albert C, Bowden GN, Benveniste RJ, Lunsford LD, Sheehan JP, Jenkinson MD. Comparison of Active Surveillance to Stereotactic Radiosurgery for the Management of Patients with an Incidental Frontobasal Meningioma—A Sub-Analysis of the IMPASSE Study. Cancers 2022;14:1300. [DOI: 10.3390/cancers14051300] [Reference Citation Analysis]
13 Davis B, Beldishevski-Shotadze O, Ibrahim Z, McHugh F, Turner C, Olson S, Faull R, Dragunow M, Law AJJ, Correia JA. Characterization of volumetric growth of intracranial meningiomas in Māori and Pasifika populations in New Zealand. ANZ J Surg 2022. [PMID: 35239240 DOI: 10.1111/ans.17564] [Reference Citation Analysis]
14 Pikis S, Mantziaris G, Islim AI, Peker S, Samanci Y, Nabeel AM, Reda WA, Abdelkarim K, El-shehaby AMN, Tawadros SR, Emad RM, Delabar V, Mathieu D, Lee C, Yang H, Licsak R, Hanuska J, Alvarez RM, Patel DN, Kondziolka D, Bernstein K, Moreno NM, Tripathi M, Speckter H, Albert C, Bowden GN, Benveniste RJ, Lunsford DL, Jenkinson MD, Sheehan J. Stereotactic radiosurgery versus active surveillance for incidental, convexity meningiomas: a matched cohort analysis from the IMPASSE study. J Neurooncol. [DOI: 10.1007/s11060-022-03953-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Amano T, Nakamizo A, Murata H, Miyamatsu Y, Mugita F, Yamashita K, Noguchi T, Nagata S. Preoperative Prediction of Intracranial Meningioma Grade Using Conventional CT and MRI. Cureus. [DOI: 10.7759/cureus.21610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mantziaris G, Pikis S, Samanci Y, Peker S, Nabeel AM, Reda WA, Tawadros SR, El-shehaby AMN, Abdelkarim K, Emad RM, Delabar V, Mathieu D, Lee C, Yang H, Liscak R, Hanuska J, Alvarez RM, Moreno NM, Tripathi M, Speckter H, Albert C, Benveniste RJ, Bowden GN, Patel DN, Kondziolka D, Bernstein K, Lunsford LD, Jenkinson MD, Islim AI, Sheehan J. Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study. J Neurooncol. [DOI: 10.1007/s11060-021-03923-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Islim AI, Millward CP, Piper RJ, Fountain DM, Mehta S, Kolamunnage-Dona R, Ali U, Koszdin SD, Georgious T, Mills SJ, Brodbelt AR, Mathew RK, Santarius T, Jenkinson MD; IMPACT Study Investigators, International Consortium on Meningioma (ICOM) and British Neurosurgical Trainee Research Collaborative (BNTRC). External validation and recalibration of an incidental meningioma prognostic model - IMPACT: protocol for an international multicentre retrospective cohort study. BMJ Open 2022;12:e052705. [PMID: 35042706 DOI: 10.1136/bmjopen-2021-052705] [Reference Citation Analysis]
18 Denysenko AP, Moskalenko RA. BIBLIOMETRIC ANALYSIS OF THE SCIENTIFIC LITERATURE ON MENINGIOMAS WITH CALCIFICATION. EUMJ 2022;10:98-108. [DOI: 10.21272/eumj.2022;10(1):98-108] [Reference Citation Analysis]
19 Yamada S, Kijima N, Nakagawa T, Hirayama R, Kinoshita M, Kagawa N, Kishima H. How Much Tumor Volume Is Responsible for Development of Clinical Symptoms in Patients With Convexity, Parasagittal, and Falx Meningiomas? Front Neurol 2021;12:769656. [PMID: 34867757 DOI: 10.3389/fneur.2021.769656] [Reference Citation Analysis]
20 Graillon T, Tabouret E, Chinot O. Chemotherapy and targeted therapies for meningiomas: what is the evidence? Curr Opin Neurol 2021;34:857-67. [PMID: 34629433 DOI: 10.1097/WCO.0000000000001002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Hosainey SAM, Bouget D, Reinertsen I, Sagberg LM, Torp SH, Jakola AS, Solheim O. Are there predilection sites for intracranial meningioma? A population-based atlas. Neurosurg Rev 2021. [PMID: 34674099 DOI: 10.1007/s10143-021-01652-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Richardson GE, Gillespie CS, Mustafa MA, Taweel BA, Bakhsh A, Kumar S, Keshwara SM, Ali T, John B, Brodbelt AR, Chavredakis E, Mills SJ, May C, Millward CP, Islim AI, Jenkinson MD. Clinical Outcomes Following Re-Operations for Intracranial Meningioma. Cancers (Basel) 2021;13:4792. [PMID: 34638276 DOI: 10.3390/cancers13194792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Raban D, Patel SH, Honce JM, Rubinstein D, DeWitt PE, Timpone VM. Intracranial meningioma surveillance using volumetrics from T2-weighted MRI. J Neuroimaging 2021. [PMID: 34506680 DOI: 10.1111/jon.12926] [Reference Citation Analysis]
24 Xiao D, Liu J, Hu T, Shah Nayaz BM, Jiang X, Zhang F, Yan P. Simple Ways to Estimate Meningioma Volume: Can ABC- and SH-Derived Methods Be Used in Clinical Practice Reliably? J Oncol 2021;2021:9712287. [PMID: 34475954 DOI: 10.1155/2021/9712287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mohmed AI, Kumaria A, White B. Risk of confirmatory bias: Parafalcine meningioma mimicking acute subarachnoid haemorrhage. Interdisciplinary Neurosurgery 2021;25:101155. [DOI: 10.1016/j.inat.2021.101155] [Reference Citation Analysis]
26 Alshibany AM, Al-Husaini HH. Late Recurrence of Metastatic Meningioma in the Lung in a Patient with Endometrial Cancer: A Case Report. Am J Case Rep 2021;22:e930708. [PMID: 34248139 DOI: 10.12659/AJCR.930708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Withrow DR, Devesa SS, Deapen D, Petkov V, Van Dyke AL, Adamo M, Armstrong TS, Gilbert MR, Linet MS. Nonmalignant meningioma and vestibular schwannoma incidence trends in the United States, 2004-2017. Cancer 2021;127:3579-90. [PMID: 34160068 DOI: 10.1002/cncr.33553] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Boto J, Guatta R, Fitsiori A, Hofmeister J, Meling TR, Vargas MI. Is Contrast Medium Really Needed for Follow-up MRI of Untreated Intracranial Meningiomas? AJNR Am J Neuroradiol 2021;42:1421-8. [PMID: 34117017 DOI: 10.3174/ajnr.A7170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
29 Delgado-López PD, Montalvo-Afonso A, Martín-Alonso J, Martín-Velasco V, Castilla-Díez JM, Galacho-Harriero AM, Ortega-Cubero S, Sánchez-Rodríguez A, Rodríguez-Salazar A. Volumetric growth rate of incidental asymptomatic meningiomas: a single-center prospective cohort study. Acta Neurochir (Wien) 2021;163:1665-75. [PMID: 33751215 DOI: 10.1007/s00701-021-04815-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Giammattei L, di Russo P, Starnoni D, Passeri T, Bruneau M, Meling TR, Berhouma M, Cossu G, Cornelius JF, Paraskevopoulos D, Zazpe I, Jouanneau E, Cavallo LM, Benes V, Seifert V, Tatagiba M, Schroeder HWS, Goto T, Ohata K, Al-Mefty O, Fukushima T, Messerer M, Daniel RT, Froelich S. Petroclival meningiomas: update of current treatment and consensus by the EANS skull base section. Acta Neurochir (Wien) 2021;163:1639-63. [PMID: 33740134 DOI: 10.1007/s00701-021-04798-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
31 Bi WL, Nayak L, Meredith DM, Driver J, Du Z, Hoffman S, Li Y, Lee EQ, Beroukhim R, Rinne M, McFaline-Figueroa R, Chukwueke U, McCluskey C, Gaffey S, Cherniack AD, Stefanik J, Doherty L, Taubert C, Cifrino M, LaFrankie D, Graillon T, Wen PY, Ligon KL, Al-Mefty O, Huang RY, Muzikansky A, Chiocca EA, Santagata S, Dunn IF, Reardon DA. Activity of PD-1 blockade with Nivolumab among patients with recurrent atypical/anaplastic meningioma: Phase II trial results. Neuro Oncol 2021:noab118. [PMID: 34015129 DOI: 10.1093/neuonc/noab118] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
32 Yamada S, Kinoshita M, Nakagawa T, Hirayama R, Kijima N, Kagawa N, Kishima H. The Impact of 5-Year Tumor Doubling Time to Predict the Subsequent Long-Term Natural History of Asymptomatic Meningiomas. World Neurosurg 2021;151:e943-9. [PMID: 34020064 DOI: 10.1016/j.wneu.2021.05.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Boaro A, Kaczmarzyk JR, Kavouridis VK, Harary M, Mammi M, Dawood H, Shea A, Cho EY, Juvekar P, Noh T, Rana A, Ghosh S, Arnaout O. Deep neural networks allow expert-level brain meningioma detection, segmentation and improvement of current clinical practice.. [DOI: 10.1101/2021.05.11.21256429] [Reference Citation Analysis]
34 Gillespie CS, Islim AI, Taweel BA, Millward CP, Kumar S, Rathi N, Mehta S, Haylock BJ, Thorp N, Gilkes CE, Lawson DDA, Mills SJ, Chavredakis E, Farah JO, Brodbelt AR, Jenkinson MD. The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring. J Neurooncol 2021;153:239-49. [PMID: 33886110 DOI: 10.1007/s11060-021-03761-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
35 Magill ST, Vagefi MR, Ehsan MU, McDermott MW. Sphenoid wing meningiomas. Handb Clin Neurol 2020;170:37-43. [PMID: 32586507 DOI: 10.1016/B978-0-12-822198-3.00026-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Bowers DC, Verbruggen LC, Kremer LCM, Hudson MM, Skinner R, Constine LS, Sabin ND, Bhangoo R, Haupt R, Hawkins MM, Jenkinson H, Khan RB, Klimo P Jr, Pretorius P, Ng A, Reulen RC, Ronckers CM, Sadighi Z, Scheinemann K, Schouten-van Meeteren N, Sugden E, Teepen JC, Ullrich NJ, Walter A, Wallace WH, Oeffinger KC, Armstrong GT, van der Pal HJH, Mulder RL. Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol 2021;22:e196-206. [PMID: 33845037 DOI: 10.1016/S1470-2045(20)30688-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
37 Ekaireb RI, Edwards CS, Ali MS, Nguyen MP, Daggubati V, Aghi MK, Theodosopoulos PV, McDermott MW, Magill ST. Meningioma surgical outcomes and complications in patients aged 75 years and older. J Clin Neurosci 2021;88:88-94. [PMID: 33992210 DOI: 10.1016/j.jocn.2021.03.032] [Reference Citation Analysis]
38 Turner N, Kaye AH, Paldor I. Metastases to meningioma-review and meta-analysis. Acta Neurochir (Wien) 2021;163:699-709. [PMID: 33389125 DOI: 10.1007/s00701-020-04661-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
39 Toland A, Huntoon K, Dahiya SM. Meningioma: A Pathology Perspective. Neurosurgery 2021;89:11-21. [PMID: 33588439 DOI: 10.1093/neuros/nyab001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
40 Islim AI, Kolamunnage-Dona R, Mohan M, Moon RDC, Crofton A, Haylock BJ, Rathi N, Brodbelt AR, Mills SJ, Jenkinson MD. A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro Oncol 2020;22:278-89. [PMID: 31603516 DOI: 10.1093/neuonc/noz160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 28.0] [Reference Citation Analysis]
41 Paun L, Gondar R, Borrelli P, Meling TR. Foramen magnum meningiomas: a systematic review and meta-analysis. Neurosurg Rev 2021. [PMID: 33507444 DOI: 10.1007/s10143-021-01478-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Ikawa F, Isobe N, Michihata N, Oya S, Ohata K, Saito K, Yoshida K, Fushimi K, Yasunaga H, Tominaga T, Kurisu K. In-Hospital Complications After Surgery in Elderly Patients with Asymptomatic or Minor Symptom Meningioma: A Nationwide Registry Study. World Neurosurg 2021;148:e459-70. [PMID: 33444840 DOI: 10.1016/j.wneu.2021.01.001] [Reference Citation Analysis]
43 Samarut E, Lugat A, Amelot A, Scharbarg E, Hadjadj S, Primot C, Loussouarn D, Thillays F, Buffenoir K, Cariou B, Drui D, Roualdes V. Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma. J Neurooncol 2021;152:115-23. [PMID: 33392938 DOI: 10.1007/s11060-020-03683-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
44 Pikis S, Bunevicius A, Sheehan J. Outcomes from treatment of asymptomatic skull base meningioma with stereotactic radiosurgery. Acta Neurochir (Wien) 2021;163:83-8. [PMID: 33211178 DOI: 10.1007/s00701-020-04648-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
45 Pecchioli G, Battista F, Puppa AD. SRS in Incidental Meningioma: Whether to Treat and When. Stereotactic Radiosurgery for the Treatment of Central Nervous System Meningiomas 2021. [DOI: 10.1007/978-3-030-79419-4_14] [Reference Citation Analysis]
46 Güdük M, Bozkurt B, Ekşi MŞ, Usseli Mİ, Pamir MN. Pre-operative predictive factors of grade II and III meningiomas. Acibadem Universitesi Saglik Bilimleri Dergisi 2020;12:1-6. [DOI: 10.31067/acusaglik.834505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Weber DC, Bizzocchi N, Bolsi A, Jenkinson MD. Proton Therapy for Intracranial Meningioma for the Treatment of Primary/Recurrent Disease Including Re-Irradiation. Front Oncol 2020;10:558845. [PMID: 33381447 DOI: 10.3389/fonc.2020.558845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Sato M, Tamura R, Morimoto Y, Oishi Y, Yoshida K, Toda M. Quiescent and Activated Fibroblasts in Lateral Ventricular Meningioma With a Dura-like Membrane. World Neurosurg 2021;147:e215-24. [PMID: 33316485 DOI: 10.1016/j.wneu.2020.12.025] [Reference Citation Analysis]
49 Balasa A, Hurghis C, Tamas F, Chinezu R. Surgical Strategies and Clinical Outcome of Large to Giant Sphenoid Wing Meningiomas: A Case Series Study. Brain Sci 2020;10:E957. [PMID: 33317116 DOI: 10.3390/brainsci10120957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Collin A, Copol C, Pianet V, Colin T, Engelhardt J, Kantor G, Loiseau H, Saut O, Taton B. Spatial mechanistic modeling for prediction of the growth of asymptomatic meningiomas. Comput Methods Programs Biomed 2021;199:105829. [PMID: 33348072 DOI: 10.1016/j.cmpb.2020.105829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
51 Maurer R, Daggubati L, Ba DM, Liu G, Leslie D, Goyal N, Zacharia BE. Mental health disorders in patients with untreated meningiomas: an observational cohort study using the nationwide MarketScan database. Neurooncol Pract 2020;7:507-13. [PMID: 33014391 DOI: 10.1093/nop/npaa025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
52 Cannizzaro D, Tropeano MP, Zaed I, De Robertis M, Olei S, Vindigni M, Pegolo E, Bagatto D, Cardia A, Maira G, Fornari M, Skrap M, Ius T. Intracranial Meningiomas in the Elderly: Clinical, Surgical and Economic Evaluation. A Multicentric Experience. Cancers (Basel) 2020;12:E2685. [PMID: 32962243 DOI: 10.3390/cancers12092685] [Reference Citation Analysis]
53 Näslund O, Skoglund T, Farahmand D, Bontell TO, Jakola AS. Indications and outcome in surgically treated asymptomatic meningiomas: a single-center case-control study. Acta Neurochir (Wien) 2020;162:2155-63. [PMID: 32016587 DOI: 10.1007/s00701-020-04244-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
54 Zhao L, Zhao W, Hou Y, Wen C, Wang J, Wu P, Guo Z. An Overview of Managements in Meningiomas. Front Oncol 2020;10:1523. [PMID: 32974188 DOI: 10.3389/fonc.2020.01523] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
55 Omer S, Murat B, Ferrat D, Selcuk D, Hakan G, Bora U, Onurhan C, Fatih O, Bahar D. Multimodality management of cavernous sinus meningiomas with less extensive surgery followed by subsequent irradiation: Implications for an improved toxicity profile. J Surg Surgical Res 2020;6:056-061. [DOI: 10.17352/2455-2968.000098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
56 Liyanage UA, Mathangasinghe Y, Wijerathne PK, Vithoosan S, Pallewatte A. Location and Diameter of Intracranial Meningioma as Predictors of Peritumoral Brain Oedema and Mass Effect. J Med Imaging Radiat Sci 2020;51:411-6. [PMID: 32423785 DOI: 10.1016/j.jmir.2020.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Islim AI, Mohan M, Moon RDC, Rathi N, Kolamunnage-Dona R, Crofton A, Haylock BJ, Mills SJ, Brodbelt AR, Jenkinson MD. Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort. World Neurosurg 2020;138:e725-35. [PMID: 32200011 DOI: 10.1016/j.wneu.2020.03.060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
58 Brugada-Bellsolà F, Rodríguez PT, Rodríguez-Hernández A, Alonso CJD, Muñoz JR. Clinical studies of incidental intracranial meningiomas-towards high-quality evidence-based practice. Acta Neurochir (Wien) 2020;162:671-2. [PMID: 31925541 DOI: 10.1007/s00701-020-04215-x] [Reference Citation Analysis]
59 Islim AI, Millward CP, Martin-McGill KJ, Kolamunnage-Dona R, Santarius T, Mathew RK, Haylock BJ, Mills SJ, Brodbelt AR, Jenkinson MD. Clinical studies of incidental intracranial meningiomas-towards high-quality evidence-based practice. Acta Neurochir (Wien) 2020;162:673-4. [PMID: 31938821 DOI: 10.1007/s00701-020-04214-y] [Reference Citation Analysis]
60 Verbruggen LC, Hudson MM, Bowers DC, Ronckers CM, Armstrong GT, Skinner R, Hoving EW, Janssens GO, van der Pal HJH, Kremer LCM, Mulder RL. Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors. J Neurooncol 2020;147:417-25. [PMID: 32088813 DOI: 10.1007/s11060-020-03436-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
61 Nassiri F, Zadeh G. How should we manage incidental meningiomas? Neuro Oncol 2020;22:173-4. [PMID: 31875227 DOI: 10.1093/neuonc/noz237] [Reference Citation Analysis]
62 Nakasu S, Nakasu Y. Natural History of Meningiomas: Review with Meta-analyses. Neurol Med Chir (Tokyo) 2020;60:109-20. [PMID: 32009127 DOI: 10.2176/nmc.ra.2019-0213] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
63 Christopher E, Moreton FC, Torgersen A, Foley P. Seeding of infection in previously asymptomatic meningioma. Pract Neurol 2020;20:247-8. [PMID: 31959614 DOI: 10.1136/practneurol-2019-002418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Fariselli L, Pinzi V, Morlino S, Marchetti M. Perioptic Meningiomas. CyberKnife NeuroRadiosurgery 2020. [DOI: 10.1007/978-3-030-50668-1_21] [Reference Citation Analysis]
65 Brugada-Bellsolà F, Teixidor Rodríguez P, Rodríguez-Hernández A, Garcia-Armengol R, Tardáguila M, González-Crespo A, Domínguez CJ, Rimbau JM. Growth prediction in asymptomatic meningiomas: the utility of the AIMSS score. Acta Neurochir (Wien) 2019;161:2233-40. [PMID: 31489530 DOI: 10.1007/s00701-019-04056-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
66 Yanagihara TK, Wang TJC. Commentary: Treatment of Asymptomatic Meningioma With Gamma Knife Radiosurgery: Long-Term Follow-up With Volumetric Assessment and Clinical Outcome. Neurosurgery 2019;85:E900-1. [PMID: 31225603 DOI: 10.1093/neuros/nyz222] [Reference Citation Analysis]
67 Bailo M, Gagliardi F, Boari N, Castellano A, Spina A, Mortini P. The Role of Surgery in Meningiomas. Curr Treat Options Neurol 2019;21:51. [PMID: 31560106 DOI: 10.1007/s11940-019-0587-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]